StockData
aTYR PHARMA INC logo

aTYR PHARMA INC (ATYR) stock

ATYRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$4.99−0.25 (-4.77%)

Close on Nov 17, 2026Market cap $489.46MP/E –Yield –

aTYR PHARMA operating margin

Operating margin is operating income as a percentage of revenue.

aTYR PHARMA's operating margin for the twelve months ending Dec 31, 2025 was -40856.3%. For fiscal 2025 it was -40856.3%, against -28899.6% the year before. The highest annual figure on record is -152.2% in fiscal 2020.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-40856.3%−11956.7
FY2024Dec 31, 2024-28899.6%−13341.8
FY2023Dec 31, 2023-15557.8%−15111.0
FY2022Dec 31, 2022-446.8%−294.6
FY2020Dec 31, 2020-152.2%+5292.8
FY2019Dec 31, 2019-5445.0%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2025Sep 30, 2025-14076.3%−13835.7
Q1 FY2024Mar 31, 2024-7079.1%−2679.1
Q3 FY2023Sep 30, 2023-3573.7%−230.8
Q4 FY2022Dec 31, 2022-76.5%−99.6
Q4 FY2020Dec 31, 2020-240.6%+3899.7
Q3 FY2020Sep 30, 2020-4400.0%−1412.0
Q2 FY2020Jun 30, 2020-3342.9%+2658.2
Q1 FY2020Mar 31, 202023.1%–
Q4 FY2019Dec 31, 2019-4140.3%–
Q3 FY2019Sep 30, 2019-2988.0%–
Q2 FY2019Jun 30, 2019-6001.1%–

More aTYR PHARMA figures

See a number that looks wrong?